Article
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis
9 Dec 2022
Abstract excerpt
BACKGROUND AND OBJECTIVES: Primary progressive multiple sclerosis (PPMS) displays a highly variable disease progression with a characteristic accumulation of disability, what makes difficult its diagnosis and efficient treatment. The identification of microRNAs (miRNAs)-based signature for the early detection in biological fluids could reveal promising biomarkers to provide new insights into defining MS clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
